Post-IPO Equity - Arcus Biosciences - May 28, 2020 Funding Round Profile - Cointime

Bitcoin $79,644.47 +4.43%
Ethereum $3,199.49 +5.41%
BNB $639.27 +3.33%
Optimism $1.70 +5.93%
Arbitrum $0.64 +7.21%
Solana $211.20 +6.84%
Polygon $0.41 +8.38%
Cosmos $5.39 +14.93%
Avalanche $32.10 +11.35%

Bitcoin $79,644.47 +4.43%
Ethereum $3,199.49 +5.41%
BNB $639.27 +3.33%
Optimism $1.70 +5.93%
Arbitrum $0.64 +7.21%
Solana $211.20 +6.84%
Polygon $0.41 +8.38%
Cosmos $5.39 +14.93%
Avalanche $32.10 +11.35%

Arcus Biosciences

company

Funding Round

Post-IPO Equity

Money Raised

$ 200M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Gilead Sciences	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 13, 2017	Series C	$ 107M	Aisling Capital,Biotechnology Value Fund,etc.	Detail
May 1, 2015	Series A	$ 49.70M	Celgene,The Column Group	Detail
Sep 1, 2016	Series B	$ 70M	Celgene,Droia Ventures,etc.	Detail
Mar 14, 2018	IPO	$ 120M		Detail